Table 3 Correlation between clinicopathologic features and the expression of TDO in 57 cases of HCC tissues (n = 57, χ2-test).
N | TDO2 | Expression | P-value | |
|---|---|---|---|---|
High (%) | Low (%) | |||
Age (year) | 0.258 | |||
<60 | 45 | 32 (71.1%) | 13 (28.9%) | |
≥60 | 12 | 11 (91.7%) | 1 (8.3%) | |
Gender | 0.261 | |||
Male | 46 | 33 (71.7%) | 13 (90.9%) | |
Female | 11 | 10 (28.3%) | 1 (9.1%) | |
Tumor number | 0.664 | |||
Single | 49 | 36 (73.5%) | 13 (26.5%) | |
Multiple | 8 | 7 (87.5%) | 1 (12.5%) | |
Tumor size | 0.002 | |||
<5 cm | 27 | 15 (55.6%) | 12 (44.4%) | |
≥5 cm | 30 | 28 (93.3%) | 2 (6.7%) | |
Tumor differentiation | 0.012 | |||
I–II | 37 | 24 (64.9%) | 13 (35.1%) | |
III–IV | 20 | 19 (95.0%) | 1 (5.0%) | |
Tumor location | 0.054 | |||
Left liver | 10 | 5 (50.0%) | 5 (50.0%) | |
Right liver | 42 | 34 (81.0%) | 8 (19.0%) | |
Whole liver | 5 | 4 (100.0%) | 1 (0.0%) | |
Vascular invasion | 0.083 | |||
Yes | 16 | 15 (93.8%) | 1 (6.3%) | |
No | 41 | 28 (68.3%) | 13 (31.7%) | |
Liver cirrhosis | 0.358 | |||
Yes | 29 | 20 (69.0%) | 9 (31.0%) | |
No | 28 | 23 (82.1%) | 5 (17.9%) | |
Hepatitis virus | 0.629 | |||
Yes | 6 | 4 (66.7%) | 2 (33.3%) | |
No | 51 | 39 (76.5%) | 12 (23.5%) | |
M stage | 0.049 | |||
M0 | 46 | 32 (69.6%) | 14 (32.4%) | |
M1 | 11 | 11 (100%) | 0 (0%) |
